在日本致命的阿托莫克赛丁过量服用:法医解剖案例报告
Akina Nara1, Chiho Yamada2, Yu Kozakai2
1Division of Legal Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1 Fukumuro, Miyagino-ku, Sendai-shi, Miyagi, 983-8536, Japan. akina@tohoku-mpu.ac.jp.
International journal of legal medicine
|November 23, 2025
概括
本案例报告详细介绍了一例罕见的致命的急性阿托莫西因中毒病例. 血液样本中高度的阿托莫克赛丁证实它是主要的死亡原因.
科学领域:
- 法医毒理学 法医毒理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿托莫克赛丁是全球广泛用于注意力缺陷/多动障碍 (ADHD) 的药物.
- 日本的处方从2009年开始用于儿童,2012年开始用于成人.
- 没有先前的法医解剖案例将亚托莫克西确定为急性中毒死亡的主要原因.
研究的目的:
- 报告第一个致命的急性阿托莫克赛丁中毒的法医解剖病例.
- 在致命的过量服用病例中提出毒理学发现.
主要方法:
- 对多种物质进行心脏血液的半定量查.
- 使用超高性能液体染色学-并联质谱法 (UHPLC-MS/MS) 对阿托莫丁和布罗马泽的定量分析.
主要成果:
- 检测到多种处方药物,包括atomoxetine和bromazepam.
- 血中阿托莫克赛丁 (23.2-24.0微克/毫升) 和布罗马泽 (0.71-0.78微克/毫升) 的度超过了治疗范围.
- 鉴定出急性阿托莫克赛丁中毒是死亡的主要原因.
结论:
- 致命的急性阿托莫克赛丁中毒是一种潜在的风险,即使是处方使用.
- 毒理学分析对于确定复杂过量病例中死亡原因至关重要.
- 布罗马泽被排除为导致死亡的直接因素.
相关概念视频
Prevention of Further Absorption of Poison
1.4K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.4K
Drug Toxicity: Overview
295
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
295
Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Toxidromes: Clinical Features
175
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
175
Pharmaceutical Poisoning: Potential Scenarios
116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmaceutical Poisoning: Treatment Strategies
279
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
279

![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
